936 / 1631
Pixantrone..real world experience
(Eyre et al 2016)
92 R/R DLBCL
85% refractory disease
72% had an international
prognostic index (IPI) 3–5
Median PFS 2·0 months (95%
confidence interval (CI) 1·5–2·4
Median OS was 3·4 months (95%
CI 2·7–4·5).
ORR 24% (complete response
10%; partial response 14%).